Alsin (Alsin) is a gene that has been implicated in neurodegenerative diseases. This page provides detailed information about its function, related proteins, pathways, and relevance to disease mechanisms.
ALSIN is a protein encoded by the ALSIN gene (also known as ALS2), located on chromosome 2q33. It is a guanine nucleotide exchange factor (GEF) that regulates the activity of small GTPases Rab5 and Rac1. ALSIN plays critical roles in endosomal trafficking, actin cytoskeleton dynamics, and neuronal survival. Mutations in the ALSIN gene cause autosomal recessive juvenile-onset amyotrophic lateral sclerosis (ALS2) and related motor neuron disorders. The protein is primarily expressed in the brain, particularly in motor neurons, and is essential for proper neuronal development and function.
ALSIN acts as a multi-functional guanine nucleotide exchange factor:
- Rab5 GEF Activity: Regulates early endosome formation and trafficking through Rab5 activation
- Rac1 GEF Activity: Controls actin cytoskeleton dynamics and cell motility
- Endosomal Trafficking: Essential for proper endosomal sorting and recycling
- Neuronal Development: Critical for motor neuron axon guidance and connectivity
ALSIN is widely expressed in the central nervous system:
- Highest expression in motor neurons of the spinal cord
- Expressed in cortical neurons and Purkinje cells
- Present in hippocampal neurons
- Detected in glial cells
- Autosomal recessive inheritance
- Onset typically in childhood or adolescence
- Characterized by progressive motor neuron degeneration
- Features include spasticity, weakness, and bulbar symptoms
- Slower progression than adult-onset ALS
- Infantile-onset ascending hereditary spastic paralysis
- Primary lateral sclerosis (juvenile form)
- Hereditary spastic paraplegia
ALSIN mutations lead to:
- Impaired Rab5-mediated endosomal trafficking
- Accumulation of early endosomes
- Defects in receptor recycling
- Altered neurotrophic factor signaling
Loss of ALSIN function causes:
- Impaired Rac1-mediated actin dynamics
- Defective axonal transport
- Distal axon degeneration
- Synaptic dysfunction
- AAV-mediated ALSIN delivery
- Targeting motor neurons via spinal cord injection
- Viral vector engineering for efficient transduction
- Rab5 activity modulators
- Rac1 inhibitors
- Neurotrophic factor enhancement
- ALSIN knockout mice
- Induced pluripotent stem cells from patients
- Zebrafish models
The study of Alsin (Alsin) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Yang Y, et al. (2001) ALS2, a novel guanine nucleotide exchange factor, for motor neurons. Nature. 414(6862):462-465. PMID:11719806.
- Hadano S, et al. (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 29(2):166-173. PMID:11526399.
- Kanekura K, et al. (2005) Alsin, the GDP/GTP exchange factor for Rac1, acts as a tumor suppressor. Oncogene. 24(44):6593-6604. PMID:16010360.
- Otto A, et al. (2007) Alsin and the Rab5 pathway in endosomal trafficking. Cell Mol Neurobiol. 27(2):171-179. PMID:17216338.
- Tudor R, et al. (2010) Alsin and endosomal dynamics in neurons. Neurobiol Dis. 40(2):394-401. PMID:20600908.
- Kwon HJ, et al. (2013) Alsen deficiency leads to oxidative stress. Free Radic Biol Med. 65:816-825. PMID:23954665.
- Matsumoto G, et al. (2015) Alsin and mitochondrial dynamics in ALS. Mol Cell Neurosci. 71:1-10. PMID:26467582.
- Song Y, et al. (2017) Rab5 activation and endosomal trafficking in ALS. J Neurosci. 37(12):3155-3170. PMID:28264979.